TAG’s annual Report on Tuberculosis Research Funding Trends tracks how much public, private, philanthropic, and multilateral institutions spend on TB research and development (R&D) across six areas of research: basic science, diagnostics, drugs vaccines, operational research, and infrastructure/unspecified projects. The report measures how investment totals in these research categories compare with the funding targets outlined in the Stop TB Partnership’s Global Plan to Stop TB. Published every year since 2006, the report serves as the leading reference document on TB R&D investments among researchers, activists, civil-society organizations, and policy markers working to end TB.
If you are a funder of TB R&D and would like your institution to be included in future reports, please contact tbrdtracking@treatmentactiongroup.org.
Reports in this series can be found here:
- 2023 Report on TB Research Funding Trends
- 2022 Report on TB Research Funding Trends
- 2021 Report on TB Research Funding Trends
- 2020 Report on TB Research Funding Trends
- 2019 Report on TB Research Funding Trends
- 2018 Report on TB Research Funding Trends
- 2017 Report on TB Research Funding Trends
- 2016 Report on TB Research Funding Trends
- 2015 Report on TB Research Funding Trends
- 2014 Report on TB Research Funding Trends
- 2013 Report on TB Research Funding Trends
- 2012 Report on TB Research Funding Trends
- 2011 Report on TB Research Funding Trends
- 2010 Report on TB Research Funding Trends
- 2009 Report on TB Research Funding Trends
- 2008 Report on TB Research Funding Trends
- 2007 Report on TB Research Funding Trends
- 2006 Report on TB Research Funding Trends